Carter Jaynes, radioligand therapy (RLT) production manager at Novartis, at work in the company’s *10,000-square-foot radioligand therapy (RLT) manufacturing facility…

Researchers at work in Sangamo Therapeutics' laboratory. The pioneer gene editing biotech company has filed for Chapter 11 bankruptcy protection,…

The results of a study headed by researchers at the University of Cambridge suggest that severe pneumonia has three different…

Nvidia has announced the NVIDIA BioNeMo Agent Toolkit, which turns complex scientific workflows into agent-executable tasks, including model selection, input…

VectorBuilder and MaxCyte formed a strategic partnership focused on co-developing a new gene delivery solution using VectorBuilder’s MiniVec™ plasmid system…

Credit: Cytomos Cytomos reports that it is showcasing its flagship cell analytic intelligence platform AuraCyt®, together with its novel Celledonia®…

Credit: Alena Butusava / iStock / Getty Images Plus Schizophrenia’s genetic landscape just expanded dramatically. A new study in Nature…

Credit: KATERYNA KON/ Science Photo Library /Getty Images Prions are best known for their role in rare, fatal neurodegenerative diseases.…

Two AbbVie researchers at work. AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, in a deal designed to…

Word Autism made with colorful cubes and puzzle pieces on green background, flat lay The prevalence of autism spectrum disorder…